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Purpose: The aim of this study was to assess the possible paracrine effect of bone morpho-
geneticprotein-2 (BMP-2) at the experimental site on the adjacent control site for validat-
ing a rabbit calvarial defect model as a means of verifying the effect of BMP-2.
Methods: Sixteen rabbits were divided into two groups (n=8 in each) according to wheth-
er or not BMP-2 would be used. Two circular defects (8 mm in diameter) were created side 
by side, 2 mm apart, in the calvarium of all of the rabbits. In each animal, one of the de-
fects was grafted with either BMP-2-loaded carrier or carrier material alone. The control 
defects adjacent to these grafted defects, designated CB (the nongrafted defect adjacent 
BMP-2-loaded carrier-grafted defect) and CC (the nongrafted defect adjacent to carrier 
only-grafted defect), respectively, were the focus of this study, and were filled only with a 
blood clot in all of the animals. Histologic observation and histomorphometric analysis 
were performed at 2 and 8 weeks (n=4 animals per point in time) after surgery.
Results: There was no noteworthy difference in the healing pattern, and no statistically 
significant differences in histomorphometric parameters such as the defect closure, new 
bone area, or total augmented area between the CC and CB groups.
Conclusions: The results of this study suggest that rabbit calvarial defects separated by a 
distance of 2 mm are suitable for evaluating the effects of BMP-2 and the control defect 
can be regarded not to be affected by BMP-2 applied defect.
Keywords: Animal experimentation, Bone morphogenetic protein 2, Bone regeneration, 
Research design.
Received: May. 9, 2014
Accepted: Jun. 4, 2014
*Correspondence: 
Seong-Ho Choi
Department of Periodontology, Yonsei University 
College of Dentistry, 50 Yonsei-ro, Seodaemun-gu, 
Seoul 120-752, Korea
E-mail: shchoi726@yuhs.ac
Tel: +82-2-2228-3189
Fax: +82-2-392-0398
Ui-Won Jung
Department of Periodontology, Yonsei University 
College of Dentistry, 50 Yonsei-ro, Seodaemun-gu, 
Seoul 120-752, Korea
E-mail: drjew@yuhs.ac
Tel: +82-2-2228-3185
Fax: +82-2-392-0398
INTRODUCTION
Numerous treatments have been developed to augment atrophic alveolar ridges, and 
their clinical efficacy has been demonstrated in both clinical and preclinical studies. How-
ever, defects with less osteogenic potential, such as vertical deficiencies, have been found 
to exhibit variable regenerative outcomes. Therefore, predictable measures for enhancing 
osteogenesis with a bone substitute have been sought. Among many efforts, the introduc-
tion of growth factors such as recombinant bone morphogeneticprotein (BMP), vascular 
endothelial growth factor, and fibroblast growth factor have certainly raised the prospect 
of predictable bone regeneration [1-4], and recombinant human BMP-2 (rhBMP-2) has 
been highlighted as a particularly promising candidate [5].
The rabbit calvarial model is one of the better-established models for evaluating the ef-
ficacies of bone substitutes. Several circular defects can be made on the rabbit calvarium, 
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with the sizes of the defects being determined according to the 
characteristics of the biomaterials being used, the healing period, 
and more importantly, the aim of individual studies [6-8]. For ex-
ample, circular 8-mm defects were created for evaluating a newly 
developed bone-graft material, with the treatment modality and 
the number of defects created differing between studies [1,6,7]. 
Rabbit calvaria have also been used for evaluating growth factors 
such as rhBMP-2 [2,9]. In order to accurately determine the effect 
of BMP-2, the experimental site grafted with carrier-material-
loaded BMP-2 should have no or only a minimal effect on the ad-
jacent, control site. Researchers ordinarily establish a negative 
control group, often a positive control group grafted with carrier 
only, and a group grafted with a well-documented carrier material 
loaded the growth factor to be tested. Moreover, individual differ-
ences among the experimental animals, even within the same spe-
cies, must be taken into consideration. Therefore, all experimental 
groups are logically required to be tested on the same animal si-
multaneously. In this sense, where several defects are created on 
the rabbit calvarium, each defect is bound to be adjacent to an-
other [2]. This has raised concerns as to whether the BMP-2 graft-
ed site has a paracrine effect on the adjacent, control defect, thus 
confounding the findings. If there is such a paracrine effect, the 
influence of the tested growth factor—and especially a low dose 
thereof—would be underestimated, thus attenuating any mea-
sured statistically significant differences between findings at the 
control and experimental sites. However, not much is currently 
known about the possible effect of BMP-2 in an experimental site 
on the adjacent, control site.
The aim of this study was therefore to determine whether graft-
ing of rhBMP-2 into an experimental site has a paracrine effect on 
the adjacent control site, thus validating the rabbit calvarial model 
as a means of verifying the effect of growth factors.
MATERIALS AND METHODS
Animals
Sixteen male New Zealand white rabbits (age, 9–20 months; 
body weight, 3–3.5 kg) were used in this study. The animals were 
housed in divided cages under standard laboratory conditions and 
fed a standard diet. The selection of experimental animals, their 
management, and the surgical protocol followed routines ap-
proved by the Institutional Animal Care and Use Committee of 
Yonsei Medical Center, Seoul, Korea.
Materials
BMP-2 was chosen as the growth factor because it is the most 
frequently used growth factor in the dental field. The BMP-2 used 
in this study was provided by Dentium (Seoul, Korea). Lyophilized 
BMP-2 was vortexed with distilled water, yielding a concentration 
of 0.05 mg/mL. Biphasic calcium phosphate (BCP) was used as the 
carrier material (OsteonII, Genoss, Suwon, Korea). OsteonII is com-
posed of hydroxyapatite and beta-tricalciumphosphate at a ratio 
of 30:70, and has a particle diameter of 0.5–1.0 mm. OsteonII was 
loaded with growth factor by soaking it in 0.1 mL of BMP-2 for 5 
minutes. The loading time was followed by previous studies [10,11].
Study design
Two circular defects (8 mm in diameter) were made side by side, 
2 mm apart on each rabbit calvarium. The rabbits were divided 
into two groups: BMP-2+carrier and carrier only (n=8 animals in 
each group). Block randomization was performed for random allo-
cation. The surgeon had not been informed of the allocation until 
the defects were created. In each animal, one of the defects was 
designated a control defect, and was filled with a blood clot only. 
The experimental sites were filled with either BCP carrier alone 
(BCP animals) or with BMP-2-loaded BCP carrier (BCP+BMP-2 ani-
mals). The control defects in each group were the subject of the 
present study, and were labeled as follows (Table 1):
.  CC group: in the BCP (carrier)-only animals, the defect located 
adjacent to the BCP-grafted site.
.  CB group: in the BCP+BMP-2 animals, the defect located adja-
cent to the site grafted with BMP-2-loaded BCP.
Surgical protocol
The rabbits were anesthetized using an intramuscular injection 
of 4:1 solution of ketamine hydrochloride (Ketalar, Yuhan, Seoul, 
Korea) and xylazine (Rompun, Bayer Korea, Seoul, Korea). The sur-
gical site was shaved, then disinfected with povidone iodine, and 
then infiltration anesthesia was induced by injection with 2% lido-
caine (lidocaineHCl, Huons, Seoul, Korea). An incision was made in 
the sagittal plane, and a full-thickness flap was elevated. Two cir-
cular defects with a diameter of 8 mm were made with a trephine 
drill; the distance between the defects was set to 2 mm (Fig. 1). 
The assigned grafting material (i.e., BCP only or BCP+BMP-2) was 
grafted into one of the defects, and a blood clot was placed into 
each of the CC and CB defects. Barrier membrane was not used in 
this study because the membrane protection could make the fa-
vorable circumstance for bone formation like guided bone regen-
eration in each control defect. The flap was repositioned and su-
tured layer by layer using 4-0 glyconate absorbable monofilament 
(Monosyn, B. Braun Aesculap AG & Co KG, Tuttlingen, Germany). 
Postoperative antibiotics were administered by daily intramuscular 
injection of gentamicin (5 mg/kg body weight) for 1 week postop-
eratively. The stitches were removed 1 week after the operation. 
The animals in each group were sacrificed at either 2 weeks (n=4 
Table 1. Group assignment.
Treatment for the defect Treatment for the adjacent defect
CC Blood clot only BCP only
CB Blood clot only BCP + BMP-2
CC: control defect adjacent to a defect grafted with biphasic calcium phosphate (BCP) 
carrier only, CB: control defect adjacent to a defect grafted with biphasic calcium 
phosphate carrier loaded with bone morphogenetic protein-2 (BMP-2).
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per group) or 8 weeks (n=4 per group) postoperatively by an over-
dose of anesthetic.
Histologic processing
Blocks that included the adjacent tissues were harvested. The 
blocks were fixed in 10% buffered formalin for 10 days, decalcified 
in 5% formic acid for 14 days, and then embedded in paraffin. Se-
rial sections were cut at 5 μm through the center of the defects. 
The two center-mostsections were selected from each block and 
stained with hematoxylin and eosin.
Evaluation methods
Clinical observations
The animals were carefully observed for any adverse signs such as 
inflammation, allergic reactions, and other complications through-
out the postoperative healing periods.
Histologic observations
The specimens were examined using a binocular microscope (DM 
LB, Leica Microsystems, Wetzlar, Germany) equipped with a camera 
(DC300F, Leica Microsystems) by a single observer (J.W.L.) who was 
blinded to the experimental conditions.
Histomorphometric analysis
Histomorphometric data regarding the following parameters 
were obtained with an automated image-analysis system (Image-
Pro Plus, Media Cybernetics, Silver Spring, MD, USA; Fig. 2): (1) the 
percentage of defect closure (DF, %)—the percentage of new bone 
in relation to the original defect length; (2) the total augmented 
area (TA, mm2)—the sum of all tissues between the defect margins, 
including new bone, connective tissue, and vessels; and (3) new 
bone area (NB, mm2)—the area of new bone between the defect 
margins.
Statistical analysis
Independent-samples t-tests were conducted using SPSS ver. 
12.0 (SPSS Inc., Chicago, IL, USA). The data are presented as mean± 
standard deviation values, and the cutoff for statistical signifi-
cance was set at P<0.05.
RESULTS
Clinical findings
Healing was uneventful during the postoperative period, and no 
sign of adverse events was observed.
Histologic findings
The histologic features were generally similar in the two groups 
at both healing times. Most of the defects in both groups were 
largely filled with fibrous connective tissue at 2 weeks postopera-
tively, and were concave in shape. A minimal amount of wedge-
shaped immature new bone was formed at the defect margins (Fig. 
3); the amount of new bone was increased at 8 weeks postopera-
tively. A demarcating line was observed in the newly formed bone. 
Bone islets were observed in some samples. The defect closure in 
the 8-week group was greater than in the 2-week group (Fig. 4).
Histomorphometric analysis
A summary of the histomorphometric analysis is given in Table 2. 
DF, NB, and TA all increased with healing time, with differences 
over time reaching statistical significance (P<0.05). However, there 
were no significant differences for each variable between the BCP- 
and BMP-2+BCP-grafted defects and the CC and CB defects, re-
spectively, at either healing time.
DISCUSSION
This study evaluated the possible paracrine effect of BMP-2 
grafted into an experimental site on the adjacent control site in a 
rabbit calvarial model. This model has frequently been used be-
Figure 1. Clinical photograph of the experiment. Two 8-mm diameter defects 
were made, 2 mm apart, in the calvaria of 16 rabbits.
Figure 2. Schematic diagram of a calvarial defect showing the parameters 
that were analyzed histomorphometrically. The calculations for various mea-
surements are shown.
Original bone Defect closure (%)=(A–B)/A×100
Augmented area=N+M
New bone area=NNew bone=N
Bone marrow,
Fibrovascular tissue=M
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cause it is relatively easily handled, the bone healing rate is good, 
and the marrow space is sufficient for stimulating new bone for-
mation [12,13]. Critical-size defects (CSDs) must be created to 
evaluate biomaterials. A CSD is defined as the smallest defect that 
would not heal spontaneously without intervention for a certain 
period of healing [14], or which results in less than 10% bone 
healing during the remaining life span of the experimental animal 
[15]. The size of CSDs in the rabbit is reportedly up to 17 mm×17 
mm [16]; however, many studies have adopted circular 8-, 6-, and 
even 5-mm defects [2,7,17,18]. Circular 8-mm diameter defects 
were chosen for the present study. Although an 8-mm defect is 
smaller than some other CSDs, this size of defect has been sug-
A
B
Figure 3. Representative photomicrographs obtained at 2 weeks postoperatively: the CC group (A) and the CB group (B) (A, B: H&E, ×40). CC: control defect 
adjacent to a defect grafted with biphasic calcium phosphate carrier only, CB: control defect adjacent to a defect grafted with biphasic calcium phosphate car-
rier loaded with bone morphogenetic protein-2.
A
B
Figure 4. Representative photomicrographs obtained at 8 weeks postoperatively: the CC group (A) and the CB group (B) (A, B: H&E, ×40). CC: control defect 
adjacent to a defect grafted with biphasic calcium phosphate carrier only, CB: control defect adjacent to a defect grafted with biphasic calcium phosphate car-
rier loaded with bone morphogenetic protein-2.
Table 2. Histomorphometric measurements.
DF (%) NB (mm2) TA (mm2)
2 Weeks 8 Weeks 2 Weeks 8 Weeks 2 Weeks 8 Weeks
CC 24.8±5.24 66.03±3.35* 0.62±0.25 3.26±0.14* 1.06±0.32 3.58±0.27*
CB 22.6±1.78 59.28±1.43* 0.67±0.19 3.13±0.28* 1.25±0.28 3.75±0.43*
Values are presented as mean±standard deviation.
DF: defect closure, NB: new bone area, TA: total augmented area.
*Statistically significant difference compared to the 2-week group (P<0.05).
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gested to be appropriate for evaluating the early phase of bone 
healing [8], and it has been shown that 8-mm defects do not fully 
heal within 8 weeks [8]. The proportions of defect closure and new 
bone were approximately 65% and 39%, respectively. Therefore, 
the bone-regenerative potential can be evaluated after a healing 
period of 8 weeks.
The advent of the growth factor era has led to some side effects 
when they are used in certain procedures, such as when BMP-2 is 
used in bone regeneration. After spinal fusion surgery using BMP-
2, ectopic bone formation was observed in a remote site that was 
not related to the surgery [19,20]. Accordingly, it is logical to sus-
pect that a grafted growth factor could also affect the area adja-
cent to the surgical site. Moreover, in experimental research using 
growth factors, it is possible that, for example, BMP-2 grafted into 
experimental sites could leak into other sites, such as neighboring 
negative or positive control sites. This is a particularly important 
issue given that researchers often establish experimental and con-
trol sites in the same bony structures. If, as is often the case, four 
8-mm circular defects are created in the rabbit calvarium, the dis-
tance between each defect margin would typically be 2–4 mm, 
and possibly smaller with inexperienced surgeons.
We set the distance between each defect margin at 2 mm in the 
present study. Histologic and histomorphometric evaluations after 
2 and 8 weeks did not reveal any differences in either the healing 
pattern or the characteristics of each variable. Sohn et al. [8] stud-
ied various sizes of circular defect in the rabbit calvarium. At 2 
weeks, the authors reported almost 1.9 mm2 of NB and a DF of 
41%, which is higher than the present study; however, this does 
not indicate that the present study was inappropriate. Rather, the 
difference might stem from the healing potentials of the individu-
al animals. At 8 weeks, the NB and DF measured in this study (CC 
group: 3.26 mm2 and 66.03%, respectively; CB group: 3.13 mm2 
and 59.28%, respectively) were similar to those reported by Sohn 
et al. [8] (3.2 mm2 and 65%, respectively).
In the present study, the BCP carrier material was soaked in 0.05 
mg/mL BMP-2 solution for use in the BCP+BMP-2 experimental 
animals. At 2 and 8 weeks, the defect grafted with the carrier-
loaded BMP-2 demonstrated statistically significant new bone for-
mation compared to the defect grafted with the carrier only (data 
not shown). These results indicate that the dose of BMP-2 used in 
the present study was effective, and support the minimal influence 
of BMP-2 on the adjacent control (CB) defect.
Within the limitations of the present study, BMP-2 application 
to experimental defects did not have a significant influence on the 
healing of the adjacent control defects in a rabbit calvarial model. 
Therefore, it can be concluded that rabbit calvarial defects that are 
separated by more than 2 mm are suitable for evaluating the ef-
fects of BMP-2. Future studies should assess this issue with other 
kinds of growth factor, lower doses of BMP-2, and extended heal-
ing periods.
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